Banner sm

ATTR amyloidosis

a panel of women engage in discussion on stage in front of a large audience October 28, 2026 Expanding Opportunities for Women to Lead Cardiovascular Science Alnylam is working with Women As One, an organization dedicated to advancing opportunities for women in cardiology. Together, we support mentorship, research Read More ›
Ester and her dog kneel on the side of a country path with green fields stretching into the distance October 24, 2026 Celebrating Caregivers – "The People Who Keep Showing Up for You" Read Ester's story and insights on caregiving while living with hereditary ATTR amyloidosis, including lessons on resilience, support, and self-care. Read More ›
Former professional football player Pete Shaw holding a football on a football field October 15, 2026 The Signs Were There: How Pete Shaw and His Team Faced an Unexpected Opponent For former professional football player Pete Shaw, recognizing the signs of hATTR-CM meant looking beyond the expected. Read his story and path to answers. Read More ›
Puzzle pieces featuring protein structures, a digital heart illustration, healthcare analytics, and a clinician, representing collaboration in ATTR research, diagnosis, and patient care August 26, 2026 Advancing Earlier Diagnosis and Coordinated Care in ATTR-CM For patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM), the path to effective care often begins with a challenge: receiving the right diagnosis before the disease irreversibly advances. Read More ›
TRITON CM clinical trial article March 27, 2026 Five Things to Know about TRITON-CM & How Community Insight is Shaping the Future of ATTR- ... TRITON-CM, Alnylam's Phase 3 clinical trial evaluating nucresiran, a third-generation investigational RNAi therapeutic for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), represents one of the largest global studies ever conducted in this disease. Read More ›
ATTR holistic care September 6, 2023 First Consensus Recommendations for Holistic Care of People Living With Hereditary ATTR Am ... The Amyloidosis Alliance has published the first-ever consensus recommendations for patient- and family-centred holistic care in ATTRv. Read More ›
Co creating with patients September 6, 2021 Co-Creating with Patients, for Patients: Addressing Unmet Needs in Conversations about AT ... Collaborating with patient organizations and patients is an essential part of our efforts to support people living with a complex rare disease like... Read More ›